Oyster Point Pharma Future Growth
Future criteria checks 2/6
Key information
59.5%
Earnings growth rate
58.9%
EPS growth rate
| Biotechs earnings growth | 23.2% |
| Revenue growth rate | 42.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
Recent updates
Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?
Nov 08
Oyster Point's nasal spray to be covered by largest Medicare pharmacy benefit manager
Aug 17Oyster Point Pharma, Inc. (NASDAQ:OYST) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Aug 14Oyster Point stock rises 11% after H.C. Wainwright begins coverage with Buy rating
Jul 18Oyster Therapeutics: State Of Business Is Confounding
Jun 30Is Oyster Point Pharma (NASDAQ:OYST) Using Debt In A Risky Way?
Dec 24Oyster Point Pharma (NASDAQ:OYST) Is In A Good Position To Deliver On Growth Plans
Oct 15Oyster Point Pharma starts enrollment in mid-stage Neurotrophic Keratopathy study
Jun 21Here's Why We're Not Too Worried About Oyster Point Pharma's (NASDAQ:OYST) Cash Burn Situation
May 10Need To Know: Oyster Point Pharma, Inc. (NASDAQ:OYST) Insiders Have Been Buying Shares
Feb 09
Oyster Point Pharma files US application for its lead program in dry eye disease
Dec 18Companies Like Oyster Point Pharma (NASDAQ:OYST) Are In A Position To Invest In Growth
Dec 18Oyster Point Pharma, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 289 | 11 | 42 | N/A | 3 |
| 12/31/2024 | 184 | -50 | -33 | N/A | 3 |
| 12/31/2023 | 98 | -71 | -86 | N/A | 3 |
| 12/31/2022 | 27 | -174 | -160 | N/A | 3 |
| 9/30/2022 | 20 | -177 | -166 | -166 | N/A |
| 6/30/2022 | 32 | -158 | -142 | -141 | N/A |
| 3/31/2022 | 27 | -130 | -124 | -123 | N/A |
| 12/31/2021 | 25 | -101 | -91 | -89 | N/A |
| 9/30/2021 | 18 | -81 | -71 | -69 | N/A |
| 6/30/2021 | N/A | -79 | -72 | -70 | N/A |
| 3/31/2021 | N/A | -73 | -65 | -65 | N/A |
| 12/31/2020 | N/A | -71 | -59 | -58 | N/A |
| 9/30/2020 | N/A | -68 | -54 | -54 | N/A |
| 6/30/2020 | N/A | -63 | -52 | -51 | N/A |
| 3/31/2020 | N/A | -58 | -48 | -48 | N/A |
| 12/31/2019 | N/A | -46 | -41 | -41 | N/A |
| 9/30/2019 | N/A | -30 | -28 | -28 | N/A |
| 6/30/2019 | N/A | -25 | -25 | -25 | N/A |
| 3/31/2019 | N/A | -17 | -17 | -17 | N/A |
| 12/31/2018 | N/A | -17 | -17 | -17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OYST is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OYST is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OYST is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OYST's revenue (42.9% per year) is forecast to grow faster than the US market (6.8% per year).
High Growth Revenue: OYST's revenue (42.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OYST's Return on Equity is forecast to be high in 3 years time